Tilray Brands (TLRY) Net Income Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Net Income Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -384.49% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -14.93% |
| 10 | Tilray Brands | 454.65 Mn | 394.45 Mn | 54.95 Mn | 96.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 96.82% |
| Nov 30, 2025 | 48.98% |
| Aug 31, 2025 | 104.37% |
| May 31, 2025 | -2,147.98% |
| Feb 28, 2025 | -655.87% |
| Nov 30, 2024 | -84.65% |
| Aug 31, 2024 | 37.97% |
| May 31, 2024 | -91.67% |
| Feb 29, 2024 | 91.22% |
| Nov 30, 2023 | 45.71% |
| Aug 31, 2023 | 15.09% |
| May 31, 2023 | 425.45% |
| Feb 28, 2023 | -2,378.71% |
| Nov 30, 2022 | -1,567.33% |
| Aug 31, 2022 | -90.13% |
| May 31, 2022 | -172.51% |
| Feb 28, 2022 | 120.29% |
| Nov 30, 2021 | 106.50% |
| Aug 31, 2021 | -59.14% |
| May 31, 2021 | 2,268.52% |